Haan
Germany
17
2013-02-14
The entities that hold a legal rights for patent applications filed by inventor Stropp Udo:
Udo Stropp from Haan, DE has applied for patents for these inventions. The list has both pending applications and granted patents:
Increasing multiplex level by externalization of passive reference in polymerase chain reactions
#2 | 2012-03-01MOLECULAR MARKERS FOR CANCER PROGNOSIS
#3 | 2011-07-14MOLECULAR MARKERS FOR CANCER PROGNOSIS
#4 | 2011-07-07ALGORITHMS FOR OUTCOME PREDICTION IN PATIENTS WITH NODE-POSITIVE CHEMOTHERAPY-TREATED BREAST CANCER
#5 | 2010-07-29SINGLE NUCLEOTIDE POLYMORPHISMS PREDICTING CARDIOVASCULAR DISEASE
#6 | 2009-08-27Genetic Alterations Useful For The Response Prediction of Malignant Neoplasia to Taxane-Based Medical Treatments
#7 | 2009-08-20Genetic Polymorphisms As Predictive Diagnostics For Adverse Drug Reactions (ADR) And Drug Efficacy
#8 | 2009-08-20Method for the Prediction of Adverse Drug Responses to Stains
#9 | 2009-08-06Haplotypes and polymorphisms linked to human thiopurine s-methyltransferase deficiencies
#10 | 2009-05-28Single nucleotide polymorphisms sensitively predicting adverse drug reactions (ADR) and drug efficacy
#11 | 2009-04-09Method for identifying predictive biomarkers from patient data
#12 | 2007-11-15Single Nucleotide Polymorphisms as Prognostic Tool to Diagnose Adverse Drug Reactions (Adr) and Drug Efficacy
#13 | 2007-08-30Single nucleotide polymorphisms predicting cardiovascular disease
#14 | 2007-06-07Single nucleotide polymorphisms sensitively predicting adverse drug reactions (adr) and drug efficacy
#15 | 2006-10-26Genetic polymorphisms sensitively predicting adverse drug reactions (adr) and drug efficacy
#16 | 2006-09-14Genetic polymorphisms as predictive diagnostics for adverse drug reactions (adr) and drug efficacy
#17 | 2005-06-09Single nucleotide polymorphisms predicting adverse drug reactions and medication efficacy
91356 ⎘